Pathogenesis and mechanisms of SARS-CoV-2 infection in the intestine, liver, and pancreas

Z Khreefa, MT Barbier, AR Koksal, G Love, L Del Valle - Cells, 2023 - mdpi.com
The novel coronavirus, SARS-CoV-2, rapidly spread worldwide, causing an ongoing global
pandemic. While the respiratory system is the most common site of infection, a significant …

Acid suppressant use in association with incidence and severe outcomes of COVID-19: a systematic review and meta-analysis

HB Kim, JH Kim, BJ Wolf - European Journal of Clinical Pharmacology, 2022 - Springer
Purpose Several observational studies have presented conflicting results on the association
between the use of proton pump inhibitors (PPIs) or histamine H2 receptor antagonist …

Proton pump inhibitors and risk of severe COVID-19 in older people

B Gramont, S Fayolle, D Beltramin, N Bidat… - Age and …, 2024 - academic.oup.com
Introduction Severe acute respiratory syndrome coronavirus 2 is a viral respiratory infection
that can cause systemic disorders and lead to death, particularly in older people. Proton …

A Prescribing Cascade of Proton Pump inhibitors following anticholinergic medications in older adults with dementia

SC Trenaman, A Harding, SK Bowles… - Frontiers in …, 2022 - frontiersin.org
Introduction: Prescribing cascade refers to use of a medication to treat a drug-related
adverse event. Prescribing cascades increase medication use, cost, and risk of adverse …

[HTML][HTML] Histamine-2 Receptor Antagonists and Proton Pump Inhibitors Are Associated With Reduced Risk of SARS-CoV-2 Infection Without Comorbidities Including …

B Kim, JH Jung, K Han, S Kang, E Lee… - Journal of Korean …, 2023 - synapse.koreamed.org
Background This study aimed to identify the effect of histamine-2 receptor antagonist (H2RA)
and proton pump inhibitor (PPI) use on the positivity rate and clinical outcomes of …

Consequências do uso a longo prazo de Inibidores de Bomba de Protóns (IBPs)

F de Oliveira Nunes… - Caderno …, 2024 - ojs.studiespublicacoes.com.br
Os inibidores de bomba de prótons, estão entre os medicamentos mais eficazes para a
inibição farmacológica da secreção de ácido gástrico. O objetivo desta revisão é avaliar as …

[HTML][HTML] ОЦЕНКА РИСКОВ ТЯЖЕЛОГО ТЕЧЕНИЯ COVID-19 И СЛУЧАИ НЕРАЦИОНАЛЬНОГО НАЗНАЧЕНИЯ ЛЕКАРСТВЕННЫХ ПРЕПАРАТОВ

НД Черешнева - Вестник современной клинической медицины, 2022 - cyberleninka.ru
Введение. Пандемия коронавирусной инфекции вызвала во всем мире значительное
увеличение числа госпитализаций. Госпитальная летальность среди пациентов в …

[HTML][HTML] Влияние приема ингибиторов протонного насоса на риск возникновения и течение инфекции COVID-19

АА Шептулин, ЮС Работягова - Крымский терапевтический …, 2022 - cyberleninka.ru
Анализ публикаций, посвященных влиянию ингибиторов протонного насоса (ИПН) на
частоту возникновения и течение инфекции COVID-19 свидетельствует о том, что …

The role of Proton Pump Inhibitors in COVID-19

SAG Saeedy, E Tokhi, F Mohammadi, AF Faiz… - Afghanistan Research …, 2022 - arj.af
The use of proton pump inhibitors (PPIs) has been associated with an increased risk of
severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection and severe …

ВЕСТНИК СОВРЕМЕННОЙ КЛИНИЧЕСКОЙ МЕДИЦИНЫ

НД ЧЕРЕШНЕВА - ВЕСТНИК СОВРЕМЕННОЙ КЛИНИЧЕСКОЙ …, 2022 - elibrary.ru
Введение. Пандемия коронавирусной инфекции вызвала во всем мире значительное
увеличение числа госпитализаций. Госпитальная летальность среди пациентов в …